50-155-9772

ZNF262 Rabbit anti-Human, Polyclonal, Bethyl Laboratories

Manufacturer: Bethyl Laboratories, Inc

Select a Size

Pack Size SKU Availability Price
Each of 1 50-155-9772-Each-of-1 In Stock ₹ 12,384.35

50-155-9772 - Each of 1

₹ 12,384.35

In Stock

Quantity

1

Base Price: ₹ 12,384.35

GST (18%): ₹ 2,229.183

Total Price: ₹ 14,613.533

Antigen

ZNF262

Classification

Polyclonal

Conjugate

Unconjugated

Gene

ZMYM4

Gene Alias

ZMYM4, Zinc finger MYM-type protein 4, CDIR, ZNF262, ZNF198L3

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

9202

Content And Storage

4° C

Form

Liquid

Applications

Immunoprecipitation

Concentration

1 mg/ml

Formulation

phosphate, tris citrate with 0.09% sodium azide; pH 7-8

Gene Accession No.

Q5VZL5

Gene Symbols

ZMYM4

Immunogen

Between 850 and 900

Quantity

10 μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG

Related Products

Img

Bethyl Laboratories, Inc

50-156-3229

--

Img

Bethyl Laboratories, Inc

50-155-9967

--

Img

Bethyl Laboratories, Inc

50-156-8226

--

Img

Bethyl Laboratories, Inc

50-156-0181

--

Img

Bethyl Laboratories, Inc

50-156-8229

--

Img

Bethyl Laboratories, Inc

50-156-0237

--

Img

Bethyl Laboratories, Inc

50-156-0238

--

Img

Bethyl Laboratories, Inc

50-156-8842

--

Description

  • The recommended shelf life for this product is 1 year from date of receipt
  • Based on 100% sequence identity, this antibody is predicted to react with Mouse Zinc-finger proteins contain DNA-binding domains characterized by the unique role of zinc and have a wide variety of functions such as transcriptional activation or repression
  • The protein folding and the DNA binding ability are governed by the coordination of a zinc ion
  • It has been found to be overexpressed in human lung adenocarcinomas and squamous cell carcinomas, and the overexpression of a fragment of the 3′UTR of the ZMYM4 mRNA termed Cell Death Inhibiting RNA (CDIR) protects HeLa cells from IFN-gamma-induced apoptosis, suggesting that ZMYM4 may play a role in tumorigenesis.